Log in

H02 Haw Par Corporation Limited SGX · Singapore

Haw Par Corporation (H02) news

Haw Par Corporation Limited is a public biotech or pharmaceutical company listed on SGX under the ticker H02, recorded under Singapore. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Haw Par Corporation news

We have not published a story on Haw Par Corporation yet. When there is news, it will appear here.

Questions about Haw Par Corporation

What is the ticker symbol of Haw Par Corporation?

Haw Par Corporation Limited trades under the ticker H02 on SGX.

Where is Haw Par Corporation listed?

Haw Par Corporation Limited is listed on SGX.

Which country or territory is Haw Par Corporation listed under?

Our directory records Haw Par Corporation Limited under Singapore.

What does Haw Par Corporation do?

Our directory classifies Haw Par Corporation Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Haw Par Corporation?

The ISIN recorded for Haw Par Corporation Limited is SG1D25001158.

Does aibio.space cover Haw Par Corporation?

aibio.space lists Haw Par Corporation Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Haw Par Corporation?

Companies in our directory listed in the same country and business area as Haw Par Corporation: Hyphens Pharma International, iX Biopharma, Cuprina Holdings (Cayman), CytoMed Therapeutics, Prestige BioPharma, Embracing Future Holdings.

Investor discussion: Haw Par Corporation

Members talk about Haw Par Corporation (H02). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SGX:H02 on TradingView.

Listing details

Haw Par Corporation Limited is a public biotech or pharmaceutical company listed on SGX under the ticker H02, recorded under Singapore. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Haw Par Corporation Limited
Ticker
H02
Listing
SGX
Country or territory
Singapore
Business scope
Pharmaceuticals: Major
ISIN
SG1D25001158
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.